ProShare Advisors
TMCI icon

ProShare Advisors’s Treace Medical Concepts TMCI Stock Holding History

ProShare Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,561
Closed -$88.6K – 2184
2025
Q1 		$88.6K Sell
10,561
-3,178
-23% -$28.6K ﹤0.01% 1861
2024
Q4 		$102K Buy
+13,739
New +$91.9K ﹤0.01% 2070

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ProShare Advisors's TMCI Position: Q2 2025 in Review

ProShare Advisors sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 10,561 shares — an estimated $88.6K sold.

ProShare Advisors first reported a position in TMCI in Q4 2024 and held it in 2 quarters. The position peaked at $102K in Q4 2024. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

  • ProShare Advisors reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
  • ProShare Advisors sold 10,561 Treace Medical Concepts shares in Q2 2025, an estimated $88.6K.
  • ProShare Advisors first reported a position in Treace Medical Concepts in Q4 2024 and held it in 2 quarters.
  • ProShare Advisors's Treace Medical Concepts position peaked at $102K in Q4 2024.
  • 125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on ProShare Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.